TY - JOUR
T1 - Minimal muscle damage after a marathon and no influence of beetroot juice on inflammation and recovery
AU - Clifford, Tom
AU - Allerton, Dean M.
AU - Brown, Meghan A.
AU - Harper, Liam
AU - Horsburgh, Steven
AU - Keane, Karen M.
AU - Stevenson, Emma J.
AU - Howatson, Glyn
PY - 2017/3/1
Y1 - 2017/3/1
N2 - This study examined whether beetroot juice (BTJ) would attenuate inflammation and muscle damage following a marathon. Using a double blind, independent group’s design, 34 runners(~16 previous marathons completed) consumed either BTJ or an isocaloric placebo (PLA) for3 days following a marathon. Maximal isometric voluntary contractions (MIVC),counter movement jumps (CMJ), muscle soreness, serum cytokines, leucocytosis, creatinekinase (CK), high sensitivity C-reactive protein (hs-CRP) and aspartate aminotransferase(AST) were measured pre, post, and on the 2 days after the marathon. CMJ and MIVC were reduced after the marathon (P<0.05) but no group differences were observed (P>0.05).Muscle soreness was increased in the day after the marathon (BTJ; 45±48 vs. PLA; 46±39mm) and had returned to baseline by day 2, irrespective of supplementation (P=0.694).Cytokines (Interleukin-6; IL-6, interleukin-8, tumour necrosis factor-α) were increased immediately post-marathon but apart from IL-6 had returned to baseline values by day 1 post.No interaction effects were evident for IL-6 (P=0.213). Leucocytes increased 1.7 fold after the race and remained elevated 2 days post, irrespective of supplement (P<0.0001). CKpeaked at 1 day post marathon (BTJ: 965±967 & PLA: 1141±979 IU·L-1) and like AST andhs-CRP, was still elevated 2 days after the marathon (P<0.05); however, no group differences were present for these variables. Beetroot juice did not attenuate inflammation or reduce muscle damage following a marathon, possibly because most of these indices were not markedly different from baseline values in the days after the marathon.
AB - This study examined whether beetroot juice (BTJ) would attenuate inflammation and muscle damage following a marathon. Using a double blind, independent group’s design, 34 runners(~16 previous marathons completed) consumed either BTJ or an isocaloric placebo (PLA) for3 days following a marathon. Maximal isometric voluntary contractions (MIVC),counter movement jumps (CMJ), muscle soreness, serum cytokines, leucocytosis, creatinekinase (CK), high sensitivity C-reactive protein (hs-CRP) and aspartate aminotransferase(AST) were measured pre, post, and on the 2 days after the marathon. CMJ and MIVC were reduced after the marathon (P<0.05) but no group differences were observed (P>0.05).Muscle soreness was increased in the day after the marathon (BTJ; 45±48 vs. PLA; 46±39mm) and had returned to baseline by day 2, irrespective of supplementation (P=0.694).Cytokines (Interleukin-6; IL-6, interleukin-8, tumour necrosis factor-α) were increased immediately post-marathon but apart from IL-6 had returned to baseline values by day 1 post.No interaction effects were evident for IL-6 (P=0.213). Leucocytes increased 1.7 fold after the race and remained elevated 2 days post, irrespective of supplement (P<0.0001). CKpeaked at 1 day post marathon (BTJ: 965±967 & PLA: 1141±979 IU·L-1) and like AST andhs-CRP, was still elevated 2 days after the marathon (P<0.05); however, no group differences were present for these variables. Beetroot juice did not attenuate inflammation or reduce muscle damage following a marathon, possibly because most of these indices were not markedly different from baseline values in the days after the marathon.
KW - Exercise recovery
KW - Neuromuscular
KW - Marathon
KW - Betalains
U2 - 10.1139/apnm-2016-0525
DO - 10.1139/apnm-2016-0525
M3 - Article
VL - 42
SP - 263
EP - 270
JO - Applied Physiology, Nutrition and Metabolism
JF - Applied Physiology, Nutrition and Metabolism
SN - 1715-5312
IS - 3
ER -